ClinicalTrials.Veeva

Menu

Vegetables Intake and Polymorphism TAS2R38 Gene by Healthy Adults

P

Poznan University of Life Sciences

Status

Completed

Conditions

Healthy Lifestyle
Diet Habit
Taste Disorders

Treatments

Behavioral: Control Group 1 personalized nutritional recommendations
Behavioral: Intervention genotype personalized nutritional recommendations
Behavioral: Control Group 2 general nutritional recommendations

Study type

Interventional

Funder types

Other

Identifiers

NCT04145453
UKB 872/19

Details and patient eligibility

About

Personalized nutrition is one of the most up to date trends in human nutrition and gains much interest of general public and scientists as well. Although we have gained some knowledge on gene-trait associations, the real effectiveness and usefulness of genotype-based nutritional recommendations is unknown. Many personalized nutrition companies are on the market today, some of them use personalized nutrition based on genotype analysis. For this reason, scientific basis of this approach should be clarified.

Our project can thus increase knowledge which can be applied in dietary counseling practice. Although we focus on increase vegetable and fruits intake, the study is designed as a proof of concept.

Full description

In humans, the TAS2R38 receptor gene is responsible for differences in the perception of bitter taste. This gene codes for a G protein that is associated with a flavor receptor regulated by phenylthiocarbamide (PTC) and propylthiouracil (PROP) ligands, which by binding to the receptor determines the degree of bitter taste. Cruciferous vegetables contain glucosinolates and isothiocyanates, which resemble PTC and PROP and thereby affect their perception of bitter taste through the TAS2R38 regulated receptor.

The polymorphism of this gene allows to distinguish three phenotypes:

  • insensitive to bitter taste [bitter-non tasters]
  • moderately sensitive to bitter taste [intermediate-bitter tasters]
  • sensitive to bitter taste [bitter taster] Previous studies have shown that people who are carriers of one PAV haplotype experience a bitter taste more than AVI / AVI homozygotes, which are less sensitive to bitter taste. Hence, the TAS2R38 gene polymorphism is associated with nutritional decisions, including choice of vegetables and coffee.

Aim of the study is to verify effectiveness of the genotype based dietary intervention in people with or without polymorphism of TAS2R38 gene.

Enrollment

174 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy

Exclusion criteria

  • injuries, chronic diseases (e.g. diabetes, metabolic syndrome, cancer, hyperthyroidism), recent diet, pregnancy, breastfeeding, limited communication to the extent that no nutritional history can be carried out, eating disorders (according to nutritional history)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

174 participants in 3 patient groups

intervention group
Experimental group
Description:
Participants with PAV haplotype will receive personalised dietary recommendations regarding consumption of fruit and vegetables. The information about genotype will be given at the beginning of study.
Treatment:
Behavioral: Intervention genotype personalized nutritional recommendations
control group 1
Sham Comparator group
Description:
Participants with PAV haplotype will receive personalised dietary recommendations regarding consumption of fruit and vegetables, but the information about genotype will be given at the end of study.
Treatment:
Behavioral: Control Group 1 personalized nutritional recommendations
Control group 2
Active Comparator group
Description:
Participants with AVI haplotype will receive general recommendations regarding consumption of fruit and vegetables.
Treatment:
Behavioral: Control Group 2 general nutritional recommendations

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems